Engflag

Isosorbide 5MG TABLET

Quick links to important sections

Isosorbide 5MG TABLET

Isosorbide 5MG TABLET_EN

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Isosorbide 5MG TABLET

What is Isosorbide 5MG TABLET?

Isosorbide 5mg tablet is a medication primarily categorized as a nitrate vasodilator. It is used in the management of cardiovascular conditions, specifically to address symptoms related to coronary artery disease.

Mechanism of Action

The active medicinal ingredient works by relaxing the smooth muscles within the walls of blood vessels. This relaxation leads to the widening of both veins and arteries, a process known as vasodilation. By increasing the diameter of these vessels, the medication facilitates improved blood flow and reduces the workload on the heart muscle.

Primary Purpose

This medication is primarily used for the prevention of angina pectoris, which is chest pain caused by reduced blood flow to the heart. By dilating the blood vessels, it ensures that the heart receives an adequate supply of oxygen-rich blood, particularly during periods of physical activity or stress that might otherwise trigger chest pain.

Key Characteristics

  • Class: Nitrate vasodilator.
  • Form: Oral tablet.
  • Function: Promotes systemic vasodilation to improve myocardial oxygen supply.
  • Usage Context: Typically used as a long-term prophylactic treatment rather than for the immediate relief of an acute angina attack.

What side effects are possible with Isosorbide 5MG TABLET?

Possible Side Effects and Safety Information

The safety profile of Isosorbide is derived from regulatory labeling and categorizes adverse reactions based on frequency of occurrence. The majority of reported side effects are related to the medication's blood vessel widening effect.

Frequency-Classified Adverse Reactions

Classification Example Adverse Reactions (SOC)
Very Common (ge 1/10) Headache (Nervous System)
Common (ge 1/100 to < 1/10) Dizziness, Hypotension, Tachycardia, Fatigue (Vascular, Nervous, General)
Uncommon (ge 1/1,000 to < 1/100) Flushing, Nausea, Vomiting, Diarrhea (Vascular, Gastrointestinal)
Rare (ge 1/10,000 to < 1/1,000) Syncope (Fainting), Allergic skin reactions (Nervous, Skin)

Headaches, the most frequently reported side effect, are very common at the start of therapy but typically lessen or resolve with continued use. Hypotension (low blood pressure) and related dizziness are also common, particularly at initiation or dose increase.

Serious Adverse Reactions

While uncommon, regulatory documents report serious adverse reactions including severe hypotension leading to circulatory collapse and syncope (fainting). Methemoglobinemia and severe allergic skin reactions, such as Stevens-Johnson Syndrome, have been reported. Aggravation of Angina Pectoris has also been noted.

Safety Restrictions and Considerations

The safety and efficacy of Isosorbide have not been established for pediatric patients or during pregnancy and lactation. Caution is necessary when treating elderly patients and those with severe hepatic or renal impairment due to increased susceptibility to severe hypotension.

There is a risk of withdrawal symptoms (e.g., increased angina frequency) if the medicine is abruptly discontinued; treatment must be gradually reduced. The medicine may impair the ability to drive or operate machinery due to potential dizziness or low blood pressure.

Overdose and Emergency Response

An overdose of Isosorbide Dinitrate is defined in regulatory documents by the clinical manifestation of profound vasodilation, resulting in severe symptomatic hypotension—a marked fall in blood pressure. Because this effect can rapidly progress to circulatory collapse, syncope, and loss of consciousness, immediate emergency medical treatment must be sought if an overdose is suspected.

Documented Manifestations and Severe Outcomes

Official regulatory documentation describes overdose presentations including a persistent, throbbing headache, vertigo, dizziness, nausea, vomiting, and visual disturbances. Skin changes, such as flushed and perspiring skin that may later become cyanotic, are also reported.

A life-threatening complication documented is methaemoglobinaemia, which severely impairs the blood’s ability to transport oxygen and may lead to cardiac arrest. This condition is noted to be particularly serious for patients with pre-existing chronic heart failure.

Emergency Management and Observation

No specific general antidote is available for this overdose; therefore, treatment is focused on immediate supportive measures for the cardiovascular system. This includes initiating plasma volume expansion to manage hypotension and, if diagnosed, administering methylene blue specifically for methaemoglobinaemia. Healthcare providers are instructed to monitor the patient’s blood pressure and pulse and continue observation for at least 12 hours after the overdose event.

Therapeutic Uses of Isosorbide 5MG TABLET

What Isosorbide 5MG TABLET treats: main uses and benefits

Isosorbide 5MG Tablet may be part of symptomatic management for conditions presenting with acute episodes of chest discomfort. As a type of nitrate vasodilator, its therapeutic use is relevant for easing the burden associated with recurrent episodes of chest discomfort. It is commonly used across conditions presenting with acute episodes and recurrent or episodic manifestations, such as angina pectoris.

Isosorbide's role involves supporting the cardiovascular system, which contributes to easing the overall symptom load by decreasing the work the heart has to do. Its action helps reduce noticeable physiological strain on the cardiovascular system, helping to ease the overall symptom burden associated with acute or episodic changes. It is applied when appropriate for managing symptoms that interfere with daily comfort. The compound is considered relevant for managing conditions characterized by periods of heightened symptoms.

Quick Fact: Relief for Symptoms Related to Physical Discomfort

Isosorbide may assist with reducing the frequency and severity of symptoms linked to organ-specific functional stress, such as during phases when symptoms become more noticeable. This may help support the patient during difficult episodes and contribute to maintaining functional stability when symptoms are more noticeable.

“This medicine is considered relevant for use across domains where additional symptomatic support is needed.”

Regulatory References

  1. MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Most adults who have been diagnosed with coronary artery disease or heart failure may be prescribed Isosorbide 5MG TABLET to help prevent chest pain (angina) or manage symptoms of heart failure. It is generally not recommended for use in children.

Contraindications and Important Precautions

Isosorbide is a nitrate medication and should not be used by individuals with certain medical conditions or who are taking specific medications. Tell your healthcare provider about all current health issues and medications.

  • Do not use Isosorbide 5MG TABLET if you have:

    • An allergy or hypersensitivity to isosorbide dinitrate, isosorbide mononitrate, nitroglycerin, or any ingredients in the tablet.
    • Severe anemia, very low blood pressure (hypotension), or certain types of acute circulatory collapse or shock.
    • Increased pressure in the head due to a recent head injury or brain bleed.
    • Certain serious heart conditions, such as hypertrophic cardiomyopathy (a thickened heart muscle) or a recent, severe heart attack.

  • Do not take this medication if you are currently using certain drugs for erectile dysfunction (e.g., sildenafil, tadalafil, vardenafil) or medications containing the soluble guanylate cyclase stimulator riociguat. Combining Isosorbide with these drugs can cause a dangerous and sudden drop in blood pressure.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Isosorbide 5MG TABLET can interact with several other medications, potentially leading to serious side effects such as a severe drop in blood pressure (hypotension).

Do not take Isosorbide 5MG TABLET if you are also taking any medication for erectile dysfunction or pulmonary arterial hypertension (PAH) that contains a PDE-5 inhibitor. The combination of isosorbide and PDE-5 inhibitors can cause a life-threatening drop in blood pressure. Examples of PDE-5 inhibitors include sildenafil, tadalafil, and vardenafil.

Other medicines that may increase the risk of low blood pressure when taken with Isosorbide 5MG TABLET include:

Drug Class Examples
Other Nitrates/Nitrites Nitroglycerin, amyl nitrite (poppers)
Calcium Channel Blockers Amlodipine, diltiazem, verapamil
Beta-blockers Metoprolol, atenolol, propranolol
Antihypertensive Agents Captopril, enalapril, losartan
Alcohol Increased risk of low blood pressure and dizziness

Inform your healthcare provider about all prescription, over-the-counter medicines, vitamins, and herbal supplements you are taking. This is essential to prevent dangerous interactions.

Mechanism of Action

Nitric Oxide Signaling and Vascular Modulation

Isosorbide functions as a prodrug that releases the signaling molecule nitric oxide (NO). The NO diffuses into vascular smooth muscle cells and activates the enzyme soluble Guanylate Cyclase (sGC), which catalyzes the synthesis of the second messenger cyclic Guanosine Monophosphate (cGMP). This molecular cascade results in the dephosphorylation of the myosin light chain, driving the relaxation of the smooth muscle within the blood vessel walls and altering the vascular muscle tone.

Hemodynamic Consequence

This muscle relaxation produces widespread vasodilation, with a predominant effect on the veins (venodilation) compared to the arteries. By widening the veins, the drug facilitates the pooling of blood in the periphery, which effectively decreases the volume and pressure of blood returning to the heart. This physiological change, known as preload reduction, is the most notable hemodynamic consequence, reducing the mechanical stress on the myocardium. The effectiveness of this mechanism is subject to pharmacological tolerance (tachyphylaxis), which occurs due to the depletion of necessary cofactors or enzyme desensitization.

Dosage and Administration Information

Official Administration Guidelines

Isosorbide Dinitrate 5mg is an immediate-release oral tablet used under a cyclic dosing schedule for long-term symptom management. The official method of administration is strictly oral; the tablets are intended to be swallowed whole with fluid, and intake may occur with or without food. This oral route is distinct from the sublingual administration used for acute symptomatic relief.

Labeled Dosing and Scheduling

Established guidelines outline specific ranges for use in adults. The usual starting dose for the immediate-release tablet is 5 mg to 20 mg per dose, taken two or three times daily. The typical maintenance range is 10 mg to 40 mg per dose. To ensure long-term effectiveness, the dosing regimen must include a mandated nitrate-free interval each day. This required period without the medicine is generally recognized to be at least 14 hours to minimize pharmacological tolerance.

Population and Procedural Rules

For older adults, standard instructions advise that dosing should be approached cautiously, usually beginning at the low end of the dosing range, due to the higher frequency of decreased organ function in this population. Use in pediatric patients is not established. If a scheduled dose is missed, instructions advise taking the dose as soon as remembered, unless it is nearly time for the next dose; doses should not be doubled. The overall protocol defines a maintenance therapy that requires careful adherence to the cyclic schedule.

Recent Clinical Evidence

Research evidence / Overview of studies for Isosorbide 5MG TABLET

Evidence for the Prevention of Stable Angina Pectoris

Isosorbide Dinitrate was studied for its application in research exploring symptom patterns in Stable Angina Pectoris, which is chest discomfort caused by compromised blood flow to the heart muscle. The core evidence comes from Randomized Controlled Trials (RCTs). These RCTs focused on outcomes related to physical discomfort and functional measures.

The research primarily explored short-term symptom changes, measuring how the medication was observed in relation to functional capacity. Findings describe patterns observed in the studies that suggest a documented change in the physiological parameters monitored following a single dose. A consistent observation noted in the research is the phenomenon of nitrate tolerance, where the monitored response to the drug appeared to diminish with continuous, non-stop dosing. Evidence is limited regarding data related to long-term outcomes of monotherapy (using the drug alone), including major cardiovascular events.

Evidence for use in Chronic Congestive Heart Failure

The medicine was evaluated in major clinical trials as part of a treatment plan for people with Chronic Congestive Heart Failure (CHF). The largest evidence in this area was observed in trials where Isosorbide Dinitrate was used in a fixed-dose combination with another vasodilator medicine (hydralazine). These large-scale RCTs were designed to examine major endpoints monitored in the long-term trials, such as all-cause mortality and the frequency of heart failure-related hospitalizations.

The strongest evidence from one of these key trials applies only to the populations studied—specifically, self-identified Black patients. The monotherapy role for long-term heart failure is not fully established by these largest trials. Comparative research continues to explore patterns against newer standard treatments, and evidence quality varies across studies depending on their design and age.

Frequently Asked Questions (FAQ)

Common questions about Isosorbide 5MG TABLET (FAQ)

Q: How quickly does Isosorbide 5MG TABLET start to work?

According to clinical pharmacology, the effects of the immediate-release tablet form are generally observed within 15 to 45 minutes of swallowing the tablet. This distinguishes it from other forms of nitrates used for immediate relief.

Q: How long does the effect of Isosorbide 5MG TABLET last?

Official information indicates that the antianginal (anti-chest pain) effects of a single immediate-release tablet dose are generally reported to last for four to six hours in clinical settings. This duration is a factor in how the overall daily dosing schedule is structured.

Q: Is it possible to develop a tolerance to Isosorbide 5MG TABLET over time?

Yes, official documents indicate that tolerance (a diminishing of the monitored effect) can occur with continuous, non-stop dosing of nitrates. The prescribed dosing regimen is designed to include a nitrate-free interval to minimize the development of tolerance.

Q: Is it mandatory to have a nitrate-free period with Isosorbide 5MG TABLET?

Regulatory documents mandate that the overall prescribed dosing regimen for this medicine must include a "nitrate-free" interval. This required period without the medicine, often at least 14 hours, is specified to minimize the development of pharmacological tolerance.

Q: Can Isosorbide 5MG TABLET be split or chewed?

Official instructions specify that the tablets are intended to be swallowed whole with fluid. The regulatory documentation does not authorize or provide instruction for splitting or chewing this specific tablet formulation.

Q: What happens if I miss a dose of Isosorbide 5MG TABLET?

Regulatory guidance advises taking the missed dose as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose should be skipped entirely. Official instructions advise that doses should not be doubled.

Q: Is Isosorbide 5MG TABLET used for long-term or short-term treatment?

Its primary therapeutic purpose, according to regulatory labeling, is for the long-term management and prevention of chest discomfort (angina). It is not intended for the relief of an acute heart attack or sudden, severe symptoms.

Q: Are there different strengths of isosorbide available besides 5MG?

Yes. Based on official product labeling, the immediate-release tablet form of isosorbide dinitrate is typically available in multiple strengths. These commonly include tablets of 5 mg, 10 mg, 20 mg, and 30 mg, depending on the specific product and manufacturer.

Q: Is Isosorbide 5MG TABLET a prescription-only medicine?

Yes. Isosorbide Dinitrate is consistently classified by government regulatory sources as a prescription-only medication. It requires an authorized prescription from a healthcare provider.

Q: Are there specific instructions for stopping Isosorbide 5MG TABLET treatment?

Regulatory information indicates that the dose is generally gradually reduced over time, rather than stopped abruptly. This process is followed to minimize the potential risk of withdrawal symptoms, such as an increased frequency of angina.

Q: Is Isosorbide 5MG TABLET the same as nitroglycerin?

While both belong to the same pharmacological class (organic nitrates), they are chemically different medicines. Regulatory documents note that Isosorbide Dinitrate has a different characteristic profile, with a slower onset and a longer duration of action than sublingual (under the tongue) nitroglycerin.

Q: Can Isosorbide 5MG TABLET be used for high blood pressure?

Official labeling limits the indicated uses of this medication to the prevention of angina pectoris and the management of chronic congestive heart failure. Essential hypertension (routine high blood pressure) is not listed as an approved indication for this medicine.

Q: Is Isosorbide 5MG TABLET a type of beta-blocker?

No. Isosorbide Dinitrate is specifically classified by regulatory bodies as an Organic Nitrate Vasodilator. Beta-blockers belong to a separate, distinct class of cardiovascular medicines.

Q: What is the difference between Isosorbide 5MG TABLET and isosorbide mononitrate?

Isosorbide Dinitrate (ISDN) is the active compound in this tablet. It is metabolized in the body, and one of the active breakdown substances it creates is isosorbide mononitrate. The regulatory documents note that ISDN is subject to a first-pass effect (meaning it's rapidly metabolized by the liver), which differs from the mononitrate form.

Q: Does Isosorbide 5MG TABLET interact with alcohol?

Official warnings indicate that consuming alcohol may increase the hypotensive and dizzying effects of the medication. This combination may increase the risk of side effects, particularly low blood pressure.

Q: Are there any food restrictions when taking Isosorbide 5MG TABLET?

Official administration instructions state the tablet can be taken either with or without food. Regulatory documents do not list specific restrictions regarding particular foods, such as grapefruit.

Q: Can a patient with liver problems take Isosorbide 5MG TABLET?

Official cautions advise that the medication should be used with caution in patients who have severe hepatic (liver) impairment. This caution is necessary due to how the body processes the medication and the potential for increased risks in this population.

Q: Is Isosorbide 5MG TABLET safe to use during pregnancy or while breastfeeding?

Regulatory labeling states that the safety and efficacy of Isosorbide Dinitrate have not been established during pregnancy or lactation. Official guidance recommends use during these periods only if the potential benefit is determined to outweigh the potential risk.

Q: Is it normal to feel dizzy after taking Isosorbide 5MG TABLET?

Yes, regulatory documents list Dizziness and light-headedness (associated with lower blood pressure) as Common adverse reactions, especially upon initiation of therapy or when changing posture rapidly.

Q: What is the physical appearance of Isosorbide 5MG TABLET?

The physical appearance of the tablet is defined in the product description, which varies by manufacturer. Typically, the 5MG tablets are described as being a specific color (often white or off-white), a certain shape (like round), and may have an identifying code or marking stamped on one side.

Q: How does Isosorbide 5MG TABLET affect the blood vessels?

The medication works by relaxing the smooth muscle found in the walls of the blood vessels. This action results in widespread vasodilation, which means the blood vessels widen. This effect is particularly noticeable in the veins.

Q: Do studies suggest Isosorbide 5MG TABLET improves exercise capacity?

Clinical studies referenced in regulatory documents report observations suggesting an association with improved exercise capacity in patients with angina. This is measured by how long or how well a person can perform physical activity during the monitored period.

Q: Is Isosorbide 5MG TABLET often prescribed with other heart medicines?

Yes. Official research and labeling, particularly for Chronic Congestive Heart Failure, describe its evaluation and use as a component of a treatment plan. It is often used in combination with other vasodilator medicines.

Q: What information should I know before starting Isosorbide 5MG TABLET?

Regulatory patient information advises being informed about several key points. Key points include the importance of adhering to the dosing schedule (to minimize tolerance), the potential for common effects like headaches and low blood pressure, and the mandatory contraindication with PDE-5 inhibitors.

Q: How to store and dispose of Isosorbide 5MG TABLET?

Official instructions specify that the tablets must be stored at Controlled Room Temperature and protected from moisture and light. Unused or expired medication must not be thrown away in household trash or flushed; it must be returned to a pharmacy or official drug take-back program for proper disposal.

How should Isosorbide 5MG TABLET be stored and disposed of?

How to Store and Dispose of Isosorbide 5MG Tablet

Official Storage Requirements

Isosorbide 5MG tablets must be stored at Controlled Room Temperature, ideally between 20 C to 25 C (68 F to 77 F). To preserve stability, it is mandatory to protect the tablets from moisture and direct light.

The medication must be kept in the original, tightly closed container and stored away from excess heat. It is critical to keep the tablets from freezing and to ensure they are out of the sight and reach of children.

Official Disposal Instructions

To comply with environmental regulations, unused or expired Isosorbide 5MG tablets must not be thrown away in household trash or disposed of via wastewater (e.g., flushing down the toilet). The medication must be returned to a pharmacy or official drug take-back program for proper and safe disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Isosorbide 5MG TABLET found in:

A-Z Index: